• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞激活基因-3是一种在活化T细胞上表达的II类主要组织相容性复合体配体,可刺激单核细胞和树突状细胞产生肿瘤坏死因子-α和白细胞介素-12。

Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells.

作者信息

Avice M N, Sarfati M, Triebel F, Delespesse G, Demeure C E

机构信息

Laboratoire de Recherche sur l'Allergie, Université de Montréal, Centre de Recherche Louis-Charles Simard, Montréal, Québec, Canada.

出版信息

J Immunol. 1999 Mar 1;162(5):2748-53.

PMID:10072520
Abstract

Lymphocyte activation gene-3 (LAG-3) is an MHC class II ligand structurally and genetically related to CD4. Although its expression is restricted to activated T cells and NK cells, the functions of LAG-3 remain to be elucidated. Here, we report on the expression and function of LAG-3 on proinflammatory bystander T cells that are activated in the absence of TCR engagement. LAG-3 is expressed at high levels on human T cells cocultured with autologous monocytes and IL-2 and synergizes with the low levels of CD40 ligand (CD40L) expressed on these cells to trigger TNF-alpha and IL-12 production by monocytes. Indeed, anti-LAG-3 mAb inhibits both IL-12 and IFN-gamma production in IL-2-stimulated cocultures of T cells and autologous monocytes. Soluble LAG-3Ig fusion protein markedly enhances IL-12 production by monocytes stimulated with infra-optimal concentrations of sCD40L, whereas it directly stimulates monocyte-derived dendritic cells (DC) for the production of TNF-alpha and IL-12, unravelling an enhanced responsiveness to MHC class II engagemenent in DC as compared with activated monocytes. Thus similar to CD40L, LAG-3 may be involved in the proinflammatory activity of cytokine-activated bystander T cells and most importantly it may directly activate DC.

摘要

淋巴细胞激活基因-3(LAG-3)是一种在结构和基因上与CD4相关的MHC II类配体。尽管其表达仅限于活化的T细胞和NK细胞,但LAG-3的功能仍有待阐明。在此,我们报告了LAG-3在未通过TCR参与而被激活的促炎性旁观者T细胞上的表达和功能。LAG-3在与自体单核细胞和IL-2共培养的人T细胞上高水平表达,并与这些细胞上低水平表达的CD40配体(CD40L)协同作用,以触发单核细胞产生TNF-α和IL-12。实际上,抗LAG-3单克隆抗体抑制T细胞和自体单核细胞的IL-2刺激共培养物中IL-12和IFN-γ的产生。可溶性LAG-3Ig融合蛋白显著增强用次优浓度的sCD40L刺激的单核细胞产生IL-12,而它直接刺激单核细胞衍生的树突状细胞(DC)产生TNF-α和IL-12,揭示了与活化的单核细胞相比,DC对MHC II类参与的反应性增强。因此,与CD40L相似,LAG-3可能参与细胞因子激活的旁观者T细胞的促炎活性,最重要的是它可能直接激活DC。

相似文献

1
Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells.淋巴细胞激活基因-3是一种在活化T细胞上表达的II类主要组织相容性复合体配体,可刺激单核细胞和树突状细胞产生肿瘤坏死因子-α和白细胞介素-12。
J Immunol. 1999 Mar 1;162(5):2748-53.
2
Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).淋巴细胞激活基因-3(CD223)诱导树突状细胞的成熟与激活。
J Immunol. 2002 Apr 15;168(8):3874-80. doi: 10.4049/jimmunol.168.8.3874.
3
T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.浸润各种肿瘤类型的T淋巴细胞表达MHC II类配体淋巴细胞激活基因-3(LAG-3):LAG-3/MHC II类相互作用在细胞间接触中的作用。
Eur J Cancer. 2001 Sep;37(13):1709-18. doi: 10.1016/s0959-8049(01)00184-8.
4
Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation.活化T细胞表达的人类淋巴细胞激活基因3分子为树突状细胞激活传递共刺激信号。
J Immunol. 2008 Mar 15;180(6):3782-8. doi: 10.4049/jimmunol.180.6.3782.
5
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.肿瘤坏死因子α和CD40配体可拮抗白细胞介素10对树突状细胞T细胞刺激能力的抑制作用。
Cancer Res. 2000 Aug 15;60(16):4485-92.
6
IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation.白细胞介素-15通过T细胞依赖性接触促进人单核细胞产生白细胞介素-12,并且在没有T细胞受体连接的情况下可能有助于白细胞介素-12介导的CD4 + T细胞分泌γ干扰素。
J Immunol. 1998 Oct 1;161(7):3408-15.
7
CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms.CD40配体激活的人单核细胞通过可溶性和细胞间接触依赖性机制放大肾小球炎症反应。
J Immunol. 1999 Aug 15;163(4):2168-75.
8
Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.人类树突状细胞通过CD40:CD40配体依赖性途径激活T淋巴细胞。
Eur J Immunol. 1996 Jun;26(6):1204-10. doi: 10.1002/eji.1830260603.
9
IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation.白细胞介素-1β增强人树突状细胞(DC)中CD40配体介导的细胞因子分泌:一种不依赖T细胞的DC激活机制。
J Immunol. 2002 Jan 15;168(2):713-22. doi: 10.4049/jimmunol.168.2.713.
10
Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.CD40配体(CD154)在炎症性肠病中的高表达及其对致病性细胞因子产生的作用。
J Immunol. 1999 Oct 1;163(7):4049-57.

引用本文的文献

1
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine.B细胞淋巴瘤免疫治疗的新视野:从免疫检查点到精准医学
Neoplasia. 2025 Jun 30;67:101206. doi: 10.1016/j.neo.2025.101206.
2
Advancing Adjuvant Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review.肝细胞癌辅助免疫治疗的进展:综述
Immunotargets Ther. 2025 Jun 25;14:631-654. doi: 10.2147/ITT.S528709. eCollection 2025.
3
The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4 + and CD8 + tumor-infiltrating lymphocytes.
抗LAG-3/PD-L1抗体FS118的四价双特异性特性介导LAG-3从CD4+和CD8+肿瘤浸润淋巴细胞上脱落。
Anticancer Drugs. 2025 Jul 1;36(6):447-458. doi: 10.1097/CAD.0000000000001705. Epub 2025 Mar 3.
4
Progress in personalized immunotherapy for patients with brain metastasis.脑转移患者个性化免疫治疗的进展。
NPJ Precis Oncol. 2025 Jan 29;9(1):31. doi: 10.1038/s41698-025-00812-0.
5
The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic Implications.YY1在CD8⁺ T细胞中调控LAG-3表达及癌症免疫逃逸中的作用:治疗意义
Cancers (Basel). 2024 Dec 25;17(1):19. doi: 10.3390/cancers17010019.
6
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.免疫检查点与非编码RNA:血液系统恶性肿瘤的开创性免疫治疗方法
Cancer Cell Int. 2024 Dec 19;24(1):410. doi: 10.1186/s12935-024-03596-8.
7
Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes.肿瘤微环境驱动肿瘤浸润淋巴细胞中共刺激分子与抑制分子之间的相互作用:对优化免疫治疗结果的启示。
Int J Mol Sci. 2024 Nov 29;25(23):12848. doi: 10.3390/ijms252312848.
8
Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms.补体系统与黏附分子在法布瑞氏病中的交锋:对发病机制和疾病机制的深入了解。
Int J Mol Sci. 2024 Nov 14;25(22):12252. doi: 10.3390/ijms252212252.
9
Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements.解读淋巴细胞激活基因-3:揭示分子机制与临床进展
Biomark Res. 2024 Oct 18;12(1):126. doi: 10.1186/s40364-024-00671-0.
10
Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review.免疫检查点LAG-3在肿瘤免疫中作用的研究进展:综述
Front Oncol. 2024 Aug 26;14:1402837. doi: 10.3389/fonc.2024.1402837. eCollection 2024.